BMC microbiology · 2025
Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Xiaohui, Li Wen, Chen Xuan, Zhang Wei, Yu Aiping, Liu Guangwen, Zheng Baolu, Gao Xin, Liu Yamin, Li Xiaoyan
Аннотация
BACKGROUND: Pertussis, a highly contagious respiratory disease caused by Bordetella pertussis (BP), poses challenges due to genomic variation that may contribute to its persistence in vaccinated populations and the development of antimicrobial resistance.
METHODS: In this study, we characterized 27 BP isolates collected from Tianjin, China in 2023, using whole-genome sequencing and multilocus genotyping (MGT) to explore their genomic diversity. For comparative analysis, we selected 165 international BP genomes to examine the genomic diversity and evolutionary traits of Tianjin strains within a global context.
RESULTS: The results revealed that all 27 isolates belonged to ST2 (100.0%), with no distinct phylogenetic clustering observed. Furthermore, phylogenetic analysis integrating 165 global BP genomes indicated that the Tianjin strains exhibited high genomic homogeneity with globally circulating strains. Specifically, 16 isolates (59.3%) carried the virulence genotype ptxA-1/ptxC-4/ptxP-3/prn-150(truncated)/fim2-1/fim3-1/fhaB-1, while 11 isolates (40.7%) carried the genotype ptxA-1/ptxC-4/ptxP-3/prn150/fim2-1/fim3-1/fhaB-1. Additionally, all 27 isolates exhibited complete resistance to erythromycin, azithromycin, clarithromycin, and clindamycin, whereas 18.5% of them were resistant to levofloxacin.
CONCLUSIONS: This study elucidates the phylogenetic, genomic characteristics, and drug sensitivity profiles of BP strains isolated in Tianjin, China, in 2023, providing valuable insights into BP persistence in vaccinated populations.
METHODS: In this study, we characterized 27 BP isolates collected from Tianjin, China in 2023, using whole-genome sequencing and multilocus genotyping (MGT) to explore their genomic diversity. For comparative analysis, we selected 165 international BP genomes to examine the genomic diversity and evolutionary traits of Tianjin strains within a global context.
RESULTS: The results revealed that all 27 isolates belonged to ST2 (100.0%), with no distinct phylogenetic clustering observed. Furthermore, phylogenetic analysis integrating 165 global BP genomes indicated that the Tianjin strains exhibited high genomic homogeneity with globally circulating strains. Specifically, 16 isolates (59.3%) carried the virulence genotype ptxA-1/ptxC-4/ptxP-3/prn-150(truncated)/fim2-1/fim3-1/fhaB-1, while 11 isolates (40.7%) carried the genotype ptxA-1/ptxC-4/ptxP-3/prn150/fim2-1/fim3-1/fhaB-1. Additionally, all 27 isolates exhibited complete resistance to erythromycin, azithromycin, clarithromycin, and clindamycin, whereas 18.5% of them were resistant to levofloxacin.
CONCLUSIONS: This study elucidates the phylogenetic, genomic characteristics, and drug sensitivity profiles of BP strains isolated in Tianjin, China, in 2023, providing valuable insights into BP persistence in vaccinated populations.